
A new study has shown that regular prescribing of antibiotics to children is still at a level that can cause them to develop a high level of drug resistance.
Although family doctors are strongly recommended to decrease antibiotic prescribing, it still remains a universal practice, write general practice Professor David Mant and colleagues at the University of Oxford.
Advertisement
A paper published in 1999 reported that over half of children aged 0-5 years in the UK are given an average of 2.2 prescriptions for a ß-lactam antibiotic like amoxicillin from their general practitioner each year.
Although a drop in prescribing has most likely resulted in about a 40 percent plunge in consumption since then, unpublished data suggest that community antibiotic prescribing is again growing, they say.
So the researchers set off to measure the consequence of antibiotic prescribing on antibiotic resistance in individual children in primary care.
They identified 119 children attending general practices in Oxfordshire with severe respiratory tract infection, of whom 71 received amoxicillin and 48 were given no antibiotic. Background medical information was recorded and throat swabs were taken at the start of the study and again at two and 12 weeks to conclude whether resistant bacteria were present. Resistant bacteria were identified by the existence of a gene which codes for antibiotic resistance.
Results showed that in children who did not get an antibiotic, there was no raise in the proportion carrying resistant bacteria in the throat from the initial level at 2 or 12 weeks.
However, in children who received an antibiotic, the number carrying resistant bacteria more than doubled at the two week follow-up, but fell back near to the original level by 12 weeks.
"These results show that prescribing amoxicillin to a child in general practice doubles the risk of recovering a resistance element from that child's throat two weeks later. Although this effect is temporary in the individual child, it may be sufficient to sustain a high level of antibiotic resistance in the population," BMJ Online quoted Professor Mant said, as asying.
Cutting resistance rates will require considerable and continual changes in antibiotic prescribing in the community, say the researchers. They suggested that alternatives include shorter courses of treatment or only prescribing antibiotics in well defined and exceptional circumstances.
The findings of the study are published online by the British Medical Journal.
Source: ANI
SRM/C
Advertisement
So the researchers set off to measure the consequence of antibiotic prescribing on antibiotic resistance in individual children in primary care.
They identified 119 children attending general practices in Oxfordshire with severe respiratory tract infection, of whom 71 received amoxicillin and 48 were given no antibiotic. Background medical information was recorded and throat swabs were taken at the start of the study and again at two and 12 weeks to conclude whether resistant bacteria were present. Resistant bacteria were identified by the existence of a gene which codes for antibiotic resistance.
Results showed that in children who did not get an antibiotic, there was no raise in the proportion carrying resistant bacteria in the throat from the initial level at 2 or 12 weeks.
However, in children who received an antibiotic, the number carrying resistant bacteria more than doubled at the two week follow-up, but fell back near to the original level by 12 weeks.
"These results show that prescribing amoxicillin to a child in general practice doubles the risk of recovering a resistance element from that child's throat two weeks later. Although this effect is temporary in the individual child, it may be sufficient to sustain a high level of antibiotic resistance in the population," BMJ Online quoted Professor Mant said, as asying.
Cutting resistance rates will require considerable and continual changes in antibiotic prescribing in the community, say the researchers. They suggested that alternatives include shorter courses of treatment or only prescribing antibiotics in well defined and exceptional circumstances.
The findings of the study are published online by the British Medical Journal.
Source: ANI
SRM/C
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News

Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.

Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.

Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.

Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.

In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial